Precise and Objective Identification of Bertolotti Syndrome Using Novel Kinematic Biomarkers
1 other identifier
observational
40
1 country
1
Brief Summary
The purpose of this study is to collect lumbar rotations, velocity, and accelerations, along with pain scores using a novel dynamic VAS device, from twenty (20) Bertolotti Syndrome patients and twenty (20) non-Bertolotti low back pain patients during range-of-motion tasks. The assessments will be analyzed to determine the differences in kinematics and continuous pain scores between Bertolotti patients and non-Bertolotti low back pain patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2024
CompletedStudy Start
First participant enrolled
January 17, 2024
CompletedFirst Posted
Study publicly available on registry
January 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
April 8, 2026
April 1, 2026
3 years
January 17, 2024
April 2, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
To identify Bertolotti's Syndrome-specific kinematic biomarkers using collected patient kinematic and real-time VAS data from range-of-motion tasks.
2025
Study Arms (2)
Bertolotti's Syndrome
Subjects with Bertolotti's Syndrome.
Non-Bertolotti's Lower Back Pain
Subjects without Bertolotti's Syndrome with lower back pain.
Eligibility Criteria
20 Bertolotti's Syndrome patients and 20 lower back pain patients
You may qualify if:
- Lower Back Pain Cohort
- Positive diagnosis of sacroiliac pain or lumbosacral facet arthritis pain
- Age ≥ 18 years
- Bertolotti's Syndrome Cohort
- Positive diagnosis of Bertolotti's Syndrome
- Age ≥ 18 years
- Positive imaging for Bertolotti's Syndrome
- Previous analgesic injection results
You may not qualify if:
- Lower Back Pain Cohort
- History of spinal deformity, previous spinal surgeries, spinal infections
- Pregnant women
- Bertolotti's Syndrome Cohort
- History of spinal deformity, previous spinal surgeries, spinal infections
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cleveland Clinic
Cleveland, Ohio, 44195, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Steinmetz, MD
The Cleveland Clinic
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chairman, Department of Neurosurgery
Study Record Dates
First Submitted
January 17, 2024
First Posted
January 26, 2024
Study Start
January 17, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
April 8, 2026
Record last verified: 2026-04